Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy

Gábor Széplaki, Emin Evren Özcan, István Osztheimer, Tamás Tahin, Béla Merkely, László Gellér

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Brugada syndrome is associated with a high risk of sudden cardiac death. Currently, the cornerstone of therapy is implantation of an implantable cardioverter defibrillator (ICD). Recently, a novel approach to preventively ablate the substrate located in the anterior epicardial region of the right ventricular outflow tract showed promising results by reducing the number of ventricular fibrillation episodes in patients with ICD. Here we report on a patient with Brugada syndrome who refused ICD therapy in whom a successful epicardial right ventricular outflow tract substrate ablation was performed. In some special cases, ablation therapy might be considered as the sole therapeutic option for these patients.

Original languageEnglish
Pages (from-to)1249.e9-1249.e11
JournalCanadian Journal of Cardiology
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with brugada syndrome refusing implantable cardioverter defibrillator therapy'. Together they form a unique fingerprint.

  • Cite this